Senior insider sale
President & CEO at CANDEL THERAPEUTICS, INC. — senior position signals high conviction
$3.41M
280.25K shares
What this filing means
TAK PAUL PETER plans to sell 280.25K shares of CANDEL THERAPEUTICS, INC. valued at approximately $3.41M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2026ACC: 0001950047-26-009295
DirectorOfficer· President & CEO
Since Jul 2021
280.25K
Shares to sell
$3.41M
Approx. market value
280.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
9/10/2026
125KPreviously Exercised Stock Options
Cash
11/21/2024
12.90KRestricted Stock Units
N/A
7/9/2024
142.34KTotal acquired280.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/10/2026 | Exercise of Stock Options Cash | 125K | — |
11/21/2024 | Previously Exercised Stock Options Cash | 12.90K | — |
7/9/2024 | Restricted Stock Units N/A | 142.34K | — |
| Total | 280.25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
280.25K
Market value
$3.41M
9/10/2026
Total
Units
280.25K
Value
$3.41M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/10/2026 | 280.25K | $3.41M | NASDAQ | Planned |
| Total | 280.25K | $3.41M | ||